Logo 661 (Ropinirole hydrochloride extended-release 12 mg)
Pill imprint Logo 661 has been identified as Ropinirole hydrochloride extended-release 12 mg.
Ropinirole is used in the treatment of parkinson's disease; restless legs syndrome; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 12 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- Logo 661
- Strength:
- 12 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Actavis Elizabeth LLC
- National Drug Code (NDC):
- 00228-3661
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
castor oil
hypromelloses
lactose monohydrate
magnesium stearate
maltodextrin
titanium dioxide
ferric oxide yellow
polyethylene glycol
polyvinyl alcohol
magnesium silicate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 42291-0717 | AvKare, Inc. |
Note: Inactive ingredients may vary.
More about ropinirole
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
